The rapid growth of the biopharmaceutical market is expected to drive the accelerated development of the pharmaceutical machinery industry

【Chemical machinery equipment network market analysis ] In recent years, driven by technological progress, industrial restructuring, and increasing payment capabilities, the growth rate of China's biopharmaceutical market has exceeded China's overall pharmaceutical market and other market segments.
Statistics show that from 2016 to 2019, the size of my country's biopharmaceutical market has increased from RMB 183.
6 billion to RMB 317.
2 billion, with a compound growth rate of 20.
0%.
According to this development trend, it is estimated that by 2025, my country's biopharmaceutical market will reach 833.
2 billion yuan.

Industry analysts believe that with the rapid development of my country's biopharmaceutical industry, the demand for equipment required for high-end R&D and industrialization in the biopharmaceutical chain will also expand, which will also bring sustained growth to the biopharmaceutical equipment market.
For domesticFor pharmaceutical equipment companies, this will undoubtedly be a great opportunity for development.
In fact, pharmaceutical equipment is the basis for the development of the biopharmaceutical industry.
The improvement and development of technology in the biopharmaceutical equipment industry is of great significance to the improvement of the quality of biomedical products and the reduction of costs, as well as the development of the entire industry.

However, it should be noted that the research and development of biopharmaceutical equipment is relatively more complicated.
In addition to the high requirements for the structural parameters, process parameters, and control methods of the equipment, the requirements for sterile and pollution-free conditions of the pharmaceutical equipment are also very high.
high.
It is reported that in order to meet the various higher demands of enterprises, domestic related equipment companies are accelerating the further upgrade of their products by continuously increasing R&D investment.  

　　From the current point of view, certain results have been achieved.
If there are companies, they will take smart manufacturing as the basic direction of corporate development.
They are committed to promoting the continuous production and smart manufacturing of biopharmaceuticals, and innovatively developed advanced key biopharmaceutical equipment (biopharmaceuticals).
Reactor , bioengineering liquid preparation module) and intelligent production platform (Bio-PAS) have greatly improved the efficiency and safety of production.  

　　In addition, there is an XXL magnetic stirrer developed and produced by the company, which can meet the needs of the biopharmaceutical industry for the large-scale production of biological agents.
The staff said that this magnetic stirrer is different from the sliding sealed stirrer.
The stirring blade of the magnetic stirrer can be isolated from the non-sterile environment by carefully designed peripheral equipment.
The magnetic coupling drive device is very strict.
Sealed; the magnetic coupling cannot enter and exit the isolation device, and the pollution risk can be close to zero.  

　　However, although the development of domestic biopharmaceutical equipment has made considerable progress, many key biopharmaceutical equipment and consumables are still heavily dependent on imports.
In this regard, the industry pointed out that domestic core equipment cannot be replaced, and will become a major obstacle to the high-quality development of the pharmaceutical equipment industry.

 

　　For the domestic biopharmaceutical equipment industry, facing the coexistence of opportunities and challenges, there is still a long way to go in the future.
It is also necessary to strengthen innovation and research and break the situation where core technology is limited to people in order to seize opportunities and take advantage of the wind.
Rise.
However, it is worth noting that the biopharmaceutical equipment industry should start from market demand whether it is transformation and upgrading or achieving high-quality development.
In order to meet the needs of the market and biopharmaceutical companies, pharmaceutical companies need to understand the needs of pharmaceutical companies more carefully, so that they can better explore and research and create new products they need.  

　　It is understood that, facing the challenge of capacity expansion of biopharmaceutical companies and the increasing demand of the upstream bioequipment industry, many pharmaceutical equipment companies have begun to take the expansion of bioequipment production capacity as an important issue for their current development.
Some companies have stated in the announcement that they are expected to invest 500 million yuan in the construction of the biopharmaceutical system equipment industrialization project.
The first phase of the investment is 350 million yuan.
It is planned to be put into operation in 3 years and reach production in 5 years, with an annual output value of 5 More than 100 million yuan.
The company stated that the construction of this project will help the company expand its bio-equipment manufacturing capacity and further enhance its overall bio-engineering solution capabilities.  

　　Original title: The rapid growth of my country's biopharmaceutical market is expected to drive the accelerated development of the pharmaceutical machinery industry